Joel D. Sendek
Director of Finance/CFO at Forward Pharma USA, LLC
Joel D. Sendek active positions
Companies | Position | Start | End |
---|---|---|---|
Forward Pharma USA, LLC | Director of Finance/CFO | - | - |
Career history of Joel D. Sendek
Former positions of Joel D. Sendek
Companies | Position | Start | End |
---|---|---|---|
SPERO THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 30/04/2017 | 07/11/2019 |
Director of Finance/CFO | 30/04/2017 | 07/11/2019 | |
Treasurer | 30/04/2017 | 07/11/2019 | |
FORWARD PHARMA A/S | Comptroller/Controller/Auditor | 04/08/2014 | 29/04/2017 |
Director of Finance/CFO | 04/08/2014 | 29/04/2017 | |
Stifel, Nicolaus & Co., Inc.
Stifel, Nicolaus & Co., Inc. Investment ManagersFinance Stifel, Nicolaus & Co., Inc. (Stifel) is a dual-registered broker-dealer and investment adviser headquartered in St. Louis, Missouri. Founded in 1890, the firm is a subsidiary of Stifel Financial Corp. (NYSE: SF), a financial service holding company. Stifel provides full-service brokerage and investment advisory services to individuals and their families, institutions and businesses, and financial advisors. | Analyst-Equity | 31/12/2011 | 30/06/2014 |
STIFEL FINANCIAL CORP. | Chief Tech/Sci/R&D Officer | 31/12/2011 | 30/06/2014 |
FM Partners Holdings LLC
FM Partners Holdings LLC Investment Banks/BrokersFinance FM Partners Holdings LLC is a broker/dealer headquartered in New York City. The firm was formerly known as Lazard Capital Markets LLC.. They are a subsidiary of LFCM Holdings LLC. | Analyst-Equity | 31/12/1999 | 30/12/2011 |
Gerard Klauer Mattison & Co., Inc. | Analyst-Equity | 31/12/1996 | - |
PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 31/12/1991 | 30/12/1996 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Analyst-Equity | 30/12/1991 | 30/12/1991 |
░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Joel D. Sendek
Rice University | Undergraduate Degree |
Statistics
International
United States | 10 |
Denmark | 2 |
Bermuda | 2 |
Operational
Analyst-Equity | 4 |
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 2 |
Sectoral
Finance | 7 |
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
STIFEL FINANCIAL CORP. | Finance |
SPERO THERAPEUTICS, INC. | Health Technology |
LAZARD, INC. | Finance |
Private companies | 7 |
---|---|
FM Partners Holdings LLC
FM Partners Holdings LLC Investment Banks/BrokersFinance FM Partners Holdings LLC is a broker/dealer headquartered in New York City. The firm was formerly known as Lazard Capital Markets LLC.. They are a subsidiary of LFCM Holdings LLC. | Finance |
Gerard Klauer Mattison & Co., Inc. | Finance |
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |
Stifel, Nicolaus & Co., Inc.
Stifel, Nicolaus & Co., Inc. Investment ManagersFinance Stifel, Nicolaus & Co., Inc. (Stifel) is a dual-registered broker-dealer and investment adviser headquartered in St. Louis, Missouri. Founded in 1890, the firm is a subsidiary of Stifel Financial Corp. (NYSE: SF), a financial service holding company. Stifel provides full-service brokerage and investment advisory services to individuals and their families, institutions and businesses, and financial advisors. | Finance |
Forward Pharma A/S
Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 2005 and is headquartered in Copenhagen, Denmark. | Health Technology |
Forward Pharma USA, LLC |
- Stock Market
- Insiders
- Joel D. Sendek
- Experience